
Femasys Inc.
Femasys Inc.(FEMY)股东结构
基于 13F 申报与流通股数据,展示机构、内部人与公众持股结构;下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · FEMY · 截至 2025年9月30日
股东结构概览
32
机构持有人数
▼ 4 vs Q2
$1.33M
机构持仓总市值
▼ $2.18M vs Q2
3.52M
总流通股
freeFloat 77.63%
3.76M
13F 申报持股数
▼ 1.37M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源:FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
FEMY 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
DAUNTLESS INVESTMENT GROUP, LLC surgical & medical instruments & apparatus | 1.73M | 6.00% | 6.00% | $610.55M | Nov 14, 2025 | ▼ 588.2K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 951.9K | 3.30% | 3.30% | $335.06M | Nov 7, 2025 | — held |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 258.2K | 89.41% | 89.41% | $91.01M | Nov 12, 2025 | ▲ 6.8K |
CLEAR CREEK FINANCIAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 138.9K | 48.10% | 48.10% | $48.95M | Nov 10, 2025 | ▼ 142.9K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 98.7K | 34.19% | 34.19% | $34.80M | Nov 12, 2025 | ▲ 1.7K |
NORTHERN TRUST CORP surgical & medical instruments & apparatus | 75.4K | 26.09% | 26.09% | $26.56M | Nov 14, 2025 | ▲ 21.8K |
STATE STREET CORP surgical & medical instruments & apparatus | 56.4K | 19.52% | 19.52% | $19.86M | Nov 14, 2025 | — held |
NWF ADVISORY SERVICES INC. surgical & medical instruments & apparatus | 47.1K | 16.29% | 16.29% | $16.58M | Oct 31, 2025 | — held |
ADVISOR GROUP HOLDINGS, INC. surgical & medical instruments & apparatus | 47.1K | 16.29% | 16.29% | $16.47M | Nov 14, 2025 | — held |
XTX TOPCO LTD surgical & medical instruments & apparatus | 44.1K | 15.28% | 15.28% | $15.55M | Nov 14, 2025 | ▲ 27.1K |
数据来源:SEC 13F 申报文件。变动标识:isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
9
增持
+93.7K 股4
新建仓
首次建仓5
减持
−837.9K 股9
清仓
完全退出净股数变化(前50家)
744.2K
+93.7K / −837.9K
净新增持仓人
-1
新建 4 个 / 退出 9 个
基于前50家最大机构持仓统计,全市场实际数量可能不同。
内幕交易买卖情绪
FEMY 内幕交易记录
数据来源:SEC Form 4
11
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Canning John Charles Chief Operating Officer | Mar 30, 2026 | Award | 150,000 | $0.38 | $57.0K | 150.0K | Form 4 ↗ |
Lee-Sepsick Kathy Chief Executive Officer | Mar 19, 2026 | Award | 68,244 | $0.58 | $39.6K | 68.2K | Form 4 ↗ |
Elefant Dov Chief Financial Officer | Mar 19, 2026 | Award | 34,122 | $0.58 | $19.8K | 34.1K | Form 4 ↗ |
Eichenbaum Kenneth D. director | Mar 19, 2026 | Award | 102,366 | $0.58 | $59.4K | 102.4K | Form 4 ↗ |
Larsen Charles director | Mar 19, 2026 | Award | 34,122 | $0.58 | $19.8K | 34.1K | Form 4 ↗ |
Eichenbaum Kenneth D. director | Mar 18, 2026 | Award | 35,200 | $0.60 | $21.1K | 35.2K | Form 4 ↗ |
Lee-Sepsick Kathy Chief Executive Officer | Feb 19, 2026 | Award | 447,000 | — | — | 447.0K | Form 4 ↗ |
Lee-Sepsick Kathy Chief Executive Officer | Feb 19, 2026 | Award | 282,000 | — | — | 282.0K | Form 4 ↗ |
Elefant Dov Chief Financial Officer | Feb 19, 2026 | Award | 173,000 | — | — | 173.0K | Form 4 ↗ |
Elefant Dov Chief Financial Officer | Feb 19, 2026 | Award | 169,000 | — | — | 169.0K | Form 4 ↗ |
数据来源:SEC Form 4。买卖方向:acquisitionOrDisposition A=买入,D=卖出。已排除 RSU 归属(M-Exempt)。
关于机构与内部人持股结构
Femasys Inc.(FEMY)主要由机构投资者持有,机构持股比例约为 100.0%。公司内部人员持股约 22.37%,散户及公众持股约占剩余的 0.00%。
Femasys Inc. 最大机构股东为 DAUNTLESS INVESTMENT GROUP, LLC,截至 September 30, 2025 持有约 1.73 million 股,占总流通股的 6.00%。
目前共有 32 家机构持有 FEMY 股票,合计持仓市值约 $1,326,962,数据来源为最新 SEC 13F 申报。
常见问题
FEMY ownershipFemasys Inc.(FEMY)主要由机构投资者持有,机构持股约 100.0%。最大股东为 DAUNTLESS INVESTMENT GROUP, LLC,持股比例 6.00%。内部人员持股约 22.37%。数据来源 SEC Form 13F,截至 September 30, 2025。